SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007500
Filing Date
2022-05-06
Accepted
2022-05-06 06:04:58
Documents
81
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20220331x10q.htm   iXBRL 10-Q 2051234
2 EX-10.1 ntra-20220331xex10d1.htm EX-10.1 42566
3 EX-31.1 ntra-20220331xex31d1.htm EX-31.1 13815
4 EX-31.2 ntra-20220331xex31d2.htm EX-31.2 14854
5 EX-32.1 ntra-20220331xex32d1.htm EX-32.1 10388
6 EX-32.2 ntra-20220331xex32d2.htm EX-32.2 10649
  Complete submission text file 0001558370-22-007500.txt   10344591

Data Files

Seq Description Document Type Size
7 EX-101.SCH ntra-20220331.xsd EX-101.SCH 60080
8 EX-101.CAL ntra-20220331_cal.xml EX-101.CAL 65788
9 EX-101.DEF ntra-20220331_def.xml EX-101.DEF 314882
10 EX-101.LAB ntra-20220331_lab.xml EX-101.LAB 597976
11 EX-101.PRE ntra-20220331_pre.xml EX-101.PRE 477805
75 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20220331x10q_htm.xml XML 2227272
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 22898704
SIC: 8071 Services-Medical Laboratories